Targeting neighbouring poly(purine.pyrimidine) sequences located in the human bcr promoter by triplex-forming oligonucleotides.

Most poly(purine.pyrimidine) [poly(R.Y)] sequences in eukaryotic genomes are interrupted by one or more base pair inversions. When the inversions are centrally located, the poly(R.Y) sequences can be regarded as the sum of two abutting sites, each potentially capable of forming a triple helix. Employing band-shift, footprinting and modeling methods we examined the formation of triple helices at a critical 27 bp poly(R.Y) sequence interrupted by two adjacent CG inversions, and located in the promoter of the human bcr gene at transcription initiation. We designed several 13-mer and 14-mer triplex-forming oligonucleotides (TFOs) capable of binding the bcr abutting sites, thereby generating different base juxtapositions at the triple helical junction, to examine whether triplex formation occurs in a cooperative manner. It is found that in 50 mM Tris/HCl, pH 7.4, 10 mM MgCl2, 2 mM spermine, 37 degrees C, the 13-and the 14-mer TFOs bind to one half of the bcr site with Delta G between -30 and -35 kJ x mol-1. However, when different 13-mer/14-mer combinations of TFOs were directed against the abutting poly(R x Y) sites, triplex formation has been found to be enhanced only for the triple helical junction formed by the 5'-A-T-3' base juxtaposition, in keeping with a partial stacking suggested from modeling analysis. On the other hand, a longer 24-mer TFO, binding noncooperatively to the same abutting sites, forms a much more stable triplex (Delta G = -51 kJ x mol-1), notwithstanding the two T x CG triads in the middle. Modeling investigations reveal that there is no continuity or propagation of base stacking involving adjacent bases of the third strand at the site of base inversion as well as on the 5' side. The data indicate that the entropy penalty of forming a triplex with two oligonucleotides is much higher than the energy gained from base stacking interactions at the triplex junction formed between the two TFOs.

[1]  F. Quadrifoglio,et al.  Anti-gene effect in live cells of AG motif triplex-forming oligonucleotides containing an increasing number of phosphorothioate linkages. , 2001, Biochemistry.

[2]  G. A. van der Marel,et al.  Downregulation of c-Ki-ras promoter activity by triplex-forming oligonucleotides endogenously generated in human 293 cells. , 2000, Antisense & nucleic acid drug development.

[3]  D. Davies,et al.  Structure of a triple helical DNA with a triplex-duplex junction. , 1999, Biochemistry.

[4]  F. Quadrifoglio,et al.  Reduction of mdr1 gene amplification in human multidrug-resistant LoVo DX cell line is promoted by triple helix-forming oligonucleotides. , 1999, Antisense & nucleic acid drug development.

[5]  D. Gowers,et al.  Towards mixed sequence recognition by triple helix formation. , 1999, Nucleic acids research.

[6]  B Scaggiante,et al.  Effect of cations on purine.purine.pyrimidine triple helix formation in mixed-valence salt solutions. , 1999, European journal of biochemistry.

[7]  G. Manzini,et al.  Formation of stable DNA triple helices within the human bcr promoter at a critical oligopurine target interrupted in the middle by two adjacent pyrimidines. , 1998, Antisense & nucleic acid drug development.

[8]  C. Hélène,et al.  Extension of the range of DNA sequences available for triple helix formation: stabilization of mismatched triplexes by acridine-containing oligonucleotides. , 1997, Nucleic acids research.

[9]  D. Gowers,et al.  DNA triple helix formation at oligopurine sites containing multiple contiguous pyrimidines. , 1997, Nucleic acids research.

[10]  M. Alunni-Fabbroni,et al.  (A,G)-oligonucleotides form extraordinary stable triple helices with a critical R.Y sequence of the murine c-Ki-ras promoter and inhibit transcription in transfected NIH 3T3 cells. , 1996, Biochemistry.

[11]  K. Weber,et al.  Triple Helix-forming Oligonucleotide Corresponding to the Polypyrimidine Sequence in the Rat 1(I) Collagen Promoter Specifically Inhibits Factor Binding and Transcription (*) , 1996, The Journal of Biological Chemistry.

[12]  B. Pettitt,et al.  Structure and stability of a model pyrimidine-purine-purine DNA triple helix with a GC.T mismatch by simulation. , 1995, Biochemistry.

[13]  P. Dervan,et al.  Cooperative Triple-Helix Formation at Adjacent DNA Sites: Sequence Composition Dependence at the Junction , 1995 .

[14]  M. Behe.  An overabundance of long oligopurine tracts occurs in the genome of simple and complex eukaryotes. , 1995, Nucleic acids research.

[15]  M. V. Van Dyke,et al.  Oligodeoxyribonucleotide length and sequence effects on intermolecular purine-purine-pyrimidine triple-helix formation. , 1994, Nucleic acids research.

[16]  M. Baccarani,et al.  Effect of unmodified triple helix‐forming oligodeoxyribonucleotide targeted to human multidrug‐resistance gene mdr1 in MDR cancer cells , 1994, FEBS letters.

[17]  D. Patel,et al.  Solution structure and hydration patterns of a pyrimidine.purine.pyrimidine DNA triplex containing a novel T.CG base-triple. , 1994, Journal of molecular biology.

[18]  M. Hogan,et al.  T.C.G triplet in an antiparallel purine.purine.pyrimidine DNA triplex. Conformational studies by NMR. , 1994, Biochemistry.

[19]  M. Sundaralingam,et al.  Molecular dynamics investigations of DNA triple helical models: unique features of the Watson-Crick duplex. , 1993, Journal of biomolecular structure & dynamics.

[20]  B. O’Malley,et al.  In vivo transcription of a progesterone-responsive gene is specifically inhibited by a triplex-forming oligonucleotide. , 1993, Nucleic acids research.

[21]  M. Distefano,et al.  Cooperative oligonucleotide-directed triple helix formation at adjacent DNA sites , 1993 .

[22]  A. Harel-Bellan,et al.  Inhibition of gene expression by triple helix-directed DNA cross-linking at specific sites. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[23]  P. Dervan,et al.  Specific recognition of CG base pairs by 2-deoxynebularine within the purine.purine.pyrimidine triple-helix motif. , 1993, Biochemistry.

[24]  V. Sasisekharan,et al.  Symmetry and molecular structure of a DNA triple helix: d(T)n.d(A)n.d(T)n. , 1993, Biochemistry.

[25]  J. Feigon,et al.  Proton nuclear magnetic resonance assignments and structural characterization of an intramolecular DNA triplex. , 1992, Journal of molecular biology.

[26]  Axel T. Brunger,et al.  X-PLOR Version 3.1: A System for X-ray Crystallography and NMR , 1992 .

[27]  N. Heisterkamp,et al.  Unique organization of the human BCR gene promoter. , 1990, Nucleic acids research.

[28]  P. Dervan,et al.  Recognition of thymine adenine.base pairs by guanine in a pyrimidine triple helix motif. , 1989, Science.

[29]  E. Canaani,et al.  Fused transcript of abl and bcr genes in chronic myelogenous leukaemia , 1985, Nature.

[30]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[31]  J. Stephenson,et al.  A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia , 1982, Nature.